Detalles de la búsqueda
1.
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Lancet Oncol
; 22(9): 1230-1239, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310904
2.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 26(2): 139-146, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145877
3.
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
Lancet Oncol
; 21(10): e488-e494, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002444
4.
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.
J Urol
; 203(1): 115-119, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31502940
5.
Exploration of baseline patient-reported side effect bother from cancer therapy.
Clin Trials
; 17(3): 332-337, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32153216
6.
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis.
J Natl Cancer Inst
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486364
7.
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 30(10): 2011-2016, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441576
8.
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.
J Clin Oncol
; 42(14): 1687-1698, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484203
9.
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.
Clin Cancer Res
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416426
10.
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 42(5): 605-613, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127780
11.
A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(4): 373-378, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271635
12.
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers.
Am Soc Clin Oncol Educ Book
; 42: 1-16, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35609225
13.
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database.
JAMA Oncol
; 8(2): 232-240, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989781
14.
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.
Clin Cancer Res
; 28(3): 441-445, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417198
15.
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.
Nat Rev Urol
; 19(1): 37-46, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508246
16.
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
Clin Cancer Res
; 28(22): 4843-4848, 2022 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727604
17.
Breaking Barriers: Addressing Issues of Inequality in Trial Enrollment and Clinical Outcomes for Patients With Kidney and Bladder Cancer.
Am Soc Clin Oncol Educ Book
; 41: e174-e181, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34061566
18.
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 27(4): 922-927, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962979
19.
A Mentored Pathway into the Sciences for Underrepresented Populations: A Newly Crafted Educational Modality for Women Exploring Career Opportunities in Science, Technology, Engineering, Mathematics, and Medicine.
Womens Health Rep (New Rochelle)
; 1(1): 413-423, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33786506
20.
Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: Renal Cell Carcinoma.
Clin Pharmacol Ther
; 107(3): 495-506, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355920